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The chemical composition and bioactive properties of two plants (Calendula oﬃcinalis L. and Mentha
cervina L.) were studied. Their nutritional value revealed a high content of carbohydrates and low fat
levels, and very similar energy values. However, they presented diﬀerent proﬁles in phenolic compounds
and fatty acids; C. oﬃcinalis presented mainly glycosylated ﬂavonols and saturated fatty acids, while
M. cervina presented mainly caﬀeoyl derivatives and polyunsaturated fatty acids. M. cervina showed the
highest concentration of phenolic compounds while C. oﬃcinalis presented higher amounts of sugars,
organic acids and tocopherols. The highest antioxidant and cytotoxic activities were obtained for the
hydromethanolic extract of M. cervina, which presented the lowest values of EC50 and exhibited cyto-
toxicity against the four tumor cell lines tested. Infusions showed no cytotoxicity for the tumor cell lines,
and none of the extracts showed toxicity against non-tumor cells. This study contributes to expand the
knowledge on both natural sources and therefore their use.
1. Introduction
Since ancient times, plants have been used as food and as
medicine. Traditional medicine systems have used them for
diﬀerent therapies, some of them are still in use today, and
have led to some important drugs. At present, natural products
and their derivatives represent more than 50% of all drugs in
clinical use. Nowadays, the use of traditional medicine is
increasing, as more and more consumers believe that the use
of medicinal plants could contribute to their health and well-
ness. These circumstances increase the interest in searching
natural products which could lead to new drugs, nutraceuticals
and functional foods. All in all, it is very important to ensure
the quality, eﬀectiveness and safety of these products, by
expanding their knowledge and research.1,2
Calendula oﬃcinalis L (Asteraceae), commonly known as
(pot) marigold, is an aromatic, erect, annual herb with yellow
to orange flowers, used in the Mediterranean region since the
time of the ancient Greeks and also known in the Indian and
Arabic cultures; it is cultivated for ornamental and medicinal
purposes. It is widely used in cosmetics, perfumes, pharma-
ceutical preparations, and food and as a colorant for natural
fabrics such as wool, cotton, linen, hemp and silk.3,4 The use
of flowers of marigold is reported in diﬀerent folk medicines
for external treatment of cuts, inflammations of the skin and
oral mucosa, wounds and venous ulcers, as well as for the
treatment of amenorrhoea, angina, fevers, gastritis, hypo-
tension, jaundice, rheumatism and vomiting.5
According to the literature, the major constituents of
C. oﬃcinalis included steroids, terpenoids, triterpenoids, phe-
nolic acids, flavonoids and carotenoids.6 Several reports experi-
mentally confirm the pharmacological activities of this plant
and also of its isolated compounds, including anti-inflamma-
tory, anti-edematous, anti-HIV,10 antibacterial and antifungal3
activities, and wound healing by in vivo assays7,8 and clinical
trials in patients with head-and-neck cancer.9 Other reported
activities include immuno-stimulating and immunomodula-
tory,11 spasmolytic, spasmogenic and gastroprotective,12,13
insecticidal,14 heart rate decrease,15 cardioprotective,16 geno-
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toxic and antigenotoxic dose-dependent,17 antioxidant4,18–20
and antitumoral eﬀects.7,21,22
Mentha cervina L. (Lamiaceae) also known as Hart’s penny-
royal, is an aromatic herb, found mainly in Eurasia and Africa.
This species of mint grows on edges of flooded areas, some-
times temporarily and has been cultivated in Central Europe
since the sixteenth century, used as a medicinal herb in part
because of its fine flavor.23 It is used traditionally as a food
seasoning, mainly in fish recipes, fish soup, together with
M. pulegium L. or as a substitute. It has also been used for its
medicinal properties in the prevention of various gastric dis-
orders and inflammation of the respiratory tract, and its essen-
tial oil has industrial applications in food conservation.24,25
The chemical composition of M. cervina essential oil has
been reported to be constituted mainly by monoterpenoids
(pulegone, isomenthone, menthone and limonene) with anti-
bacterial and antifungal activities, resulting in an alternative
of other mints for therapeutic purposes because of its lower
level of pulegone, a terpenoid ketone which is toxic to the
liver.25 The total phenolic content and total antioxidant
capacity of M. cervina aqueous extract have been reported, and
seven phenolic compounds have been identified (protocate-
chuic acid, p-coumaric acid, caﬀeic acid, chlorogenic acid,
epicatechin, orientin and rutin).26
In the present work, C. oﬃcinalis and M. cervina were
chemically characterized regarding their nutritional/energy
values, free sugars, organic acids, fatty acids and tocopherols
of the dry plants and their infusions, as commonly consumed
preparations. Furthermore, the phenolic compounds and the
bioactive properties (antioxidant and cytotoxic properties for
tumor and non-tumor cells) of the hydromethanolic extracts
and infusions of these plants were studied and compared. To
the best of author’s knowledge, the available data about the
phytochemical characterization and bioactivity of these plants
are limited, especially for M. cervina.
2. Materials and methods
2.1. Plant material and preparation of the extracts
C. oﬃcinalis (air-dried flowers) and M. cervina (air-dried leaves)
samples were purchased from two companies, Soria Natural®
from Soria, Spain, and Cantinho das Aromáticas® from Vila
Nova de Gaia, Portugal, respectively. Both companies have
their own organically grown crops. Each sample was reduced
to a fine dried powder (20 mesh) and stored in a desiccator,
protected from light, until further analysis.
To prepare the infusions, each sample (1 g) was added to
200 mL of boiled distilled water and kept for resting at room
temperature for 5 min followed by subsequent filtration
through a Whatman No. 4 paper.
For hydromethanolic extract preparation, each sample (1 g)
was extracted by stirring in 30 mL of methanol/water (80 : 20
v/v, at 25 °C at 150 rpm) for 1 h and subsequently filtered
through a Whatman paper No. 4. The residue was then
extracted with an additional portion of 30 mL of the hydro-
methanolic mixture. The combined extracts were evaporated
under reduced pressure (rotary evaporator Büchi R-210, Flawil,
Switzerland) until the complete removal of methanol, and
afterwards the aqueous phase was frozen and lyophilized
(FeeeZone 4.5, Labconco, Kansas City, MO, USA).
2.2. Standards and reagents
Acetonitrile (99.9%), n-hexane (95%) and ethyl acetate (99.8%)
were HPLC grade and obtained from Fisher Scientific (Lisbon,
Portugal) and the other solvents used were of analytical grade
and purchased from common sources. Water was obtained
from a Millipore Direct-Q purification system (TGI Pure Water
Systems, Greenville, SC, USA).
For the chemical characterization and antioxidant activity
evaluation: the fatty acid methyl ester (FAME) reference stan-
dard mixture (standard 47885-U) was purchased from Sigma-
Aldrich (St Louis, MO, USA), as also trichloroacetic acid (TCA),
sugars, organic acids and Trolox (6-hydroxy-2,5,7,8-tetra-
methylchroman-2-carboxylic acid) standards. Phenolic com-
pound standards were from Extrasynthese (Genay, France),
tocol in n-hexane (50 mg mL−1) and tocopherols (α-, β-, γ-, and
δ-isoforms) were purchased from Matreya (Plesant Gap, PA,
USA), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) was obtained
from Alfa Aesar (Ward Hill, MA, USA).
For cytotoxic property evaluation: fetal bovine serum (FBS),
L-glutamine, Hank’s saline solution (HBSS), trypsin-EDTA
(ethylenediaminetetraacetic acid), essential amino acids
(2 mM), penicillin/streptomycin solution (100 U mL−1 and
100 mg mL−1, respectively), RPMI-1640 and DMEM culture
media were from Hyclone (Logan, Utah, USA). Acetic acid,
ellipticine, sulforhodamine B (SRB), trypan blue and tris[2-
amino-2-(hydroxymethyl)propane-1,3-diol)] were purchased
from Sigma-Aldrich (St Louis, MO, USA).
2.3. Chemical characterization of the plant dry material and
infusions
2.3.1. Nutritional and energy values. Ash, proteins, fat and
carbohydrate contents (proximate composition) were analysed
in the samples (dry plant and infusions), through standard
procedures.27 To estimate the crude protein content (N × 6.25)
a macro-Kjeldahl method was applied; crude fat was deter-
mined by using a Soxhlet apparatus with petroleum ether; ash
content was determined by incineration at 600 ± 15 °C and
total carbohydrates were calculated by diﬀerence. The energy
value was calculated according to the following equation:
Energy (kcal) = 4 × (g protein + g carbohydrate) + 9 × (g fat).
For infusion, total carbohydrates were calculated on the basis
of total free sugars (section 2.3.2) and the energy value was cal-
culated taking into account those results.
2.3.2. Free sugars. Free sugars were determined by high
performance liquid chromatography coupled to a refraction
index detector (HPLC-RI; Knauer, Smartline system 1000,
Berlin, Germany), as previously described by the authors.28
Identification of sugar was made by comparing the relative
retention times of sample peaks with standards (D(–)-fructose,
D(+)-glucose, D(+)-sucrose, D(+)-trehalose and D(+)-xylose) and
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quantification was based on the RI signal response of each
standard, using the internal standard (IS, melezitose) method
or the external standard method for infusions, and by using
calibration curves obtained from the commercial standards of
each compound. Results were expressed in g per 100 g of dry
weight or in g per 100 mL of infusion.
2.3.3. Organic acids. Organic acids namely oxalic, quinic,
malic, ascorbic and citric acids were determined following a
procedure previously described by Barros et al.28 and the analy-
sis was performed by ultra-fast liquid chromatography coupled
to photodiode array detection (UFLC-PDA; Shimadzu Corpor-
ation, Kyoto, Japan), using 215 nm and 245 nm (for ascorbic
acid) as the preferred wavelengths; the quantification was per-
formed by comparison of the area of the peaks recorded at the
corresponding wavelength with calibration curves obtained
from the commercial standards of each compound. The
organic acids found were quantified by comparison of the area
of their peaks with the calibration curves obtained from the
commercial standards of each compound: oxalic acid (y =
9 × 106 x + 377 946; R2 = 0.994); quinic acid (y = 612327 x +
16 563; R2 = 1); malic acid (y = 863548 x + 55 591; R2 = 0.999);
ascorbic acid (y = 1 × 108 x + 751 815; R2 = 0.999) and citric
acid (y = 1 × 106 x + 16 276; R2 = 1). The results were expressed
in mg per 100 g of dry weight or in mg per 100 mL of infusion.
2.3.4. Tocopherols. Tocopherols were determined following
a procedure previously described by Barros et al.,28 using
a HPLC system (Knauer, Smartline system 1000, Berlin,
Germany) coupled to a fluorescence detector (FP-2020; Jasco,
Easton, USA) programmed for excitation at 290 nm and emis-
sion at 330 nm; the identification was performed by chromato-
graphic comparisons with authentic standards (α-, β-, γ-, and
δ-isoforms), while the quantification was based on the fluo-
rescence signal response of each standard, using the IS (tocol)
method and by using calibration curves obtained from the
commercial standards of each compound. The results were
expressed in μg per 100 g of dry weight or μg per 100 mL of
infusion.
2.3.5. Fatty acids. Fatty acids were determined in the crude
lipid fraction, after a trans-esterification process, by gas–liquid
chromatography with flame ionization detection (GC-FID;
DANI model GC 1000 instrument, Contone, Switzerland) as
previously described by Barros et al.28 Fatty acid identification
was made by comparing the relative retention times of FAME
peaks from samples with standards. The results were recorded
and processed using Clarity Software (DataApex, Prague, The
Czech Republic) and expressed as the relative percentage of
each fatty acid.
2.4. Phenolic compound characterization in the
hydromethanolic extracts and infusions
Chromatographic analyses were carried out on a Spherisorb S3
ODS-2 C18 column (3 μm, 4.6 × 150 mm, Waters, Milford, MA,
EUA), thermostatted at 35 °C. The mobile phase consisted of
two solvents: (A) 0.1% formic acid in water and (B) acetonitrile,
using a gradient as follows: 15% B for 5 min, 15% B to 20% B
over 5 min, 20–25% B over 10 min, 25–35% B over 10 min,
35–50% B for 10 min, and re-equilibration of the column, with
a flow rate of 0.5 mL min−1 and the injection volume 100 µL.
The spectral data for all peaks were recorded at 280 and
370 nm as preferred wavelengths. The HPLC-DAD-MS/ESI ana-
lyses were carried out using a Hewlett-Packard 1100 series
chromatograph (Hewlett-Packard 1100, Agilent Technologies,
Santa Clara, CA, USA) equipped with a diode-array detector
(DAD) and a mass detector (API 3200 Qtrap, Applied Bio-
systems, Darmstadt, Germany) connected to the HPLC system
via the PDA cell outlet.29 The identification of the diﬀerent
phenolic compounds was performed by comparison with avail-
able commercial standard compounds, or were tentatively
identified using reported data from the literature. For quanti-
tative analysis, a calibration curve for each available phenolic
standard (caﬀeic acid, 5-O-caﬀeoylquinic acid, quercetin-3-O-
rutinoside, isorhamnetin-3-O-rutinoside, kaempferol-3-O-ruti-
noside, quercetin-3-O-glucoside, isorhamnetin-3-O-glucoside,
rosmarinic acid) was constructed based on the UV signal or
when no commercial standard was available, a similar com-
pound from the same phenolic group was used as a standard.
The results were expressed in mg per g of extract or mg per mL
of infusion.
2.5. Evaluation of bioactive properties of hydromethanolic
extracts and infusions
2.5.1. In vitro antioxidant activity assays. Hydromethanolic
extracts were redissolved in methanol/water (80 : 20 v/v) to the
final concentration of 20 mg mL−1, and infusions (5 mg mL−1)
were further diluted to diﬀerent concentrations to be subjected
to the following assays. DPPH radical-scavenging activity (RSA)
was evaluated by using an ELX800 microplate reader (Bio-Tek
Instruments, Inc.; Winooski, VT, USA), and calculated as a per-
centage of DPPH discolouration using the formula: % RSA =
[(ADPPH − AS)/ADPPH] × 100, where AS is the absorbance of the
solution containing the sample at 515 nm, and ADPPH is the
absorbance of the DPPH solution. Reducing power was evalu-
ated by the capacity to convert Fe3+ into Fe2+, measuring the
absorbance at 690 nm in the microplate reader mentioned
above. Inhibition of β-carotene bleaching was evaluated
though the β-carotene/linoleate assay; the neutralization of
linoleate free radicals avoids β-carotene bleaching, which is
measured by the formula: (β-carotene absorbance after 2 h of
assay/initial absorbance) × 100. Lipid peroxidation inhibition
in porcine brain homogenates was evaluated by the decrease
in thiobarbituric acid reactive substances (TBARS); the
color intensity of the malondialdehyde-thiobarbituric acid
(MDA-TBA) was measured by its absorbance at 532 nm; the
inhibition was calculated using the following formula: Inhi-
bition ratio (%) = [(A − B)/A] × 100, where A and B were the
absorbance of the control and the sample solution, respect-
ively.28 The final results were expressed in EC50 values (mg
mL−1); sample concentration providing 50% of antioxidant
activity or 0.5 of absorbance in the reducing power assay.
Trolox was used as the positive control.
2.5.2. Cytotoxicity in tumor cell lines and in non-tumor
primary cells. Hydromethanolic extracts (final concentration
Food & Function Paper
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8 mg mL−1, redissolved in water) and infusions (5 mg mL−1)
were further diluted to diﬀerent concentrations to be subjected
to in vitro antitumor activity and hepatotoxicity evaluation.
The human tumor cell lines used were: HeLa (cervical carci-
noma), HepG2 (hepatocellular carcinoma), MCF-7 (breast
adenocarcinoma) and NCI-H460 (non-small cell lung cancer).
Each of the cell lines were plated in a 96-well plate, at an
appropriate density (7.5 × 103 cells per well for MCF-7 and
NCI-H460 and 1.0 × 104 cells per well for HeLa and HepG2)
and were allowed to attach for 24 h. Afterwards, various extract
concentrations were added to the cells and incubated for 48 h.
Afterwards, cold trichloroacetic acid (TCA 10%, 100 μL) was
used in order to bind the adherent cells and further incubated
for 60 min at 4 °C. After the incubation period, the plates were
washed with deionised water and dried and sulforhodamine B
solution (SRB 0.1% in 1% acetic acid, 100 μL) was then added
to each plate well and incubated for 30 min at room tempera-
ture. The plates were washed with acetic acid (1%) in order to
remove the unbound SRB and then air dried; the bound SRB
was solubilised with Tris (10 mM, 200 μL) and the absorbance
was measured at 540 nm using an ELX800 microplate reader
(Bio-Tek Instruments, Inc.; Winooski, VT, USA).28 The results
were expressed in GI50 values; the sample concentration that
inhibited 50% of the net cell growth. Ellipticine was used as
the positive control.
For hepatotoxicity evaluation, a freshly harvested porcine
liver, obtained from a local slaughter house, was used in order
to obtain the cell culture, designated as PLP2. The liver tissues
were rinsed in Hank’s balanced salt solution containing peni-
cillin (100 U mL−1), streptomycin (100 µg mL−1) and divided
into 1 × 1 mm3 explants. A few of these explants were trans-
ferred to tissue flasks (25 cm2) containing DMEM sup-
plemented with fetal bovine serum (FBS, 10%), nonessential
amino acids (2 mM), penicillin (100 U mL−1) and streptomycin
(100 mg mL−1) and incubated at 37 °C under a humidified
atmosphere (5% CO2). The medium was changed every two
days and the cell cultivation was continuously monitored
using a phase contrast microscope. When confluence was
reached, the cells were sub-cultured and plated in a 96-well
plate (density of 1.0 × 104 cells per well) containing DMEM
supplemented with FBS (10%), penicillin (100 U mL−1) and
streptomycin (100 µg mL−1). The growth inhibition was evalu-
ated using the SRB assay, previously described.28 The results
were expressed in GI50 values; the sample concentration that
inhibited 50% of the net cell growth. Ellipticine was used as
the positive control.
2.6. Statistical analysis
Three samples were used for each species and all the assays
were carried out in triplicate. Results were expressed as mean
values and standard deviation (SD) and analysis was
performed through a Student’s t-test with α = 0.05, using the
SPSS v. 22.0 program.
3. Results and discussion
3.1. Nutritional value and chemical characterization of
C. oﬃcinalis and M. cervina dry material and infusions
The results of the nutritional and estimated energy values
obtained in the dry plants and infusions of C. oﬃcinalis and
M. cervina are shown in Table 1. Carbohydrates, calculated by
diﬀerence for the dry plant, were the most abundant macro-
nutrients and M. cervina showed the highest values, both in
the infusions (0.05 g per 100 mL) and in dry material (86 g per
100 g dw). Mentha cervina also revealed a higher protein
content (6 g per 100 g dw), while C. oﬃcinalis showed higher
ash and fat levels (14 g per 100 g dw and 6 g per 100 g dw,
respectively). The infusion prepared using both plants did not
reveal the presence of fat, ash and proteins, therefore the
energy value was calculated taking into account total carbo-
hydrates, calculated by the total free sugar content. The energy
value calculated for the dry plants (376 kcal per 100 g dw,
on average) did not show significant diﬀerences between
C. oﬃcinalis and M. cervina (p > 0.05).
The composition of free sugars, organic acids and tocopher-
ols of the dry plants and infusions is presented in Table 2.
There is scarce information about C. oﬃcinalis, except regard-
ing its use as a cosmetic ingredient6 and its composition in
water-soluble polysaccharides,30 while no information about
M. cervina was found. Five free sugars were identified in
C. oﬃcinalis (xylose, fructose, glucose, sucrose and trehalose),
while xylose could not be found in M. cervina. Calendula oﬃci-
nalis showed higher levels of fructose (5 g per 100 g plant dw,
19 mg per 100 mL infusion), sucrose (4 g per 100 g plant dw,
14 mg per 100 mL infusion), and total free sugars
Table 1 Nutritional and energy values of plant dry material and infusions of C. oﬃcinalis and M. cervina
Dry material Infusions
C. oﬃcinalis M. cervina
Student’s t-test
p-value C. oﬃcinalis M. cervina
Student’s t-test
p-value
Ash (g per 100 g) 14 ± 1 6.9 ± 0.1 <0.001 np np —
Proteins (g per 100 g) 2.4 ± 0.5 5.9 ± 0.2 <0.001 — — —
Fat (g per 100 g) 5.6 ± 0.2 1.4 ± 0.1 <0.001 — — —
Carbohydrates (g per 100 g) 78 ± 2 85.8 ± 0.2 <0.001 0.038 ± 0.003a 0.048 ± 0.003a 0.012
Energy (kcal per 100 g) 373 ± 6 379.2 ± 0.2 0.075 0.15 ± 0.01a 0.19 ± 0.01a 0.012
np – not performed. a Values are expressed per 100 mL of infusion. In each row, p < 0.05 means significant diﬀerences.
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(12 g per 100 g plant dw, 49 mg per 100 mL infusion), while
M. cervina gave higher levels of glucose (4 g per 100 g plant dw,
16 mg per 100 mL infusion). Regarding dry plants, no signifi-
cant diﬀerences (p > 0.05) were found in the content of treha-
lose (0.6 g per 100 g plant dw on average), although this sugar
was not detected in the infusion of M. cervina.
Oxalic, quinic, malic, citric and fumaric acids were identi-
fied in C. oﬃcinalis and M. cervina. The highest total content
was found in C. oﬃcinalis (2830 mg per 100 g plant dw, 3.0 mg
per 100 mL infusion), and the most abundant one was citric
acid (963 mg per 100 g plant dw, 2.6 mg per 100 mL infusion).
In the C. oﬃcinalis infusion, only oxalic, citric and fumaric
acids were detected, while citric acid was the only organic acid
identified in M. cervina, probably due to degradation of some
of these compounds by heat during the preparation procedure.
Calendula oﬃcinalis presented three tocopherol isoforms
(α, β and γ-tocopherols), while M. cervina presented only two
(α and δ-tocopherols). In infusions, only α-tocopherol was
detected, the low tocopherol concentration in infusion
samples could also be due to the extraction procedure (water
extraction), and not only due to thermal treatment during the
extraction process. Calendula oﬃcinalis showed the highest
concentration of tocopherols (23 mg per 100 g plant dw,
0.9 mg per 100 mL infusion) and α-tocopherol was the major
isoform (19 mg per 100 g marigold plant dw; 2 mg per 100 mL
Hart’s pennyroyal plant).
The fatty acid (FA) composition of both dry plants is shown
in Table 3. The obtained fatty acid profiles were significantly
diﬀerent. In C. oﬃcinalis, saturated fatty acids (SFA; 77%),
mainly palmitic acid (C16:0, 36%) and myristic acid (C14:0,
25%), predominated over polyunsaturated fatty acids (PUFA;
21%); while in M. cervina PUFA (56%), mainly α-linolenic acid
(C18:3n3, 46%), predominated over SFA (34%).
3.2. Analysis of phenolic compounds in C. oﬃcinalis and
M. cervina hydromethanolic extracts and infusions
The phenolic compounds found in C. oﬃcinalis and M. cervina
infusions and hydromethanolic extracts are listed in Tables 4
and 5, and their HPLC profiles can be observed in Fig. 1. The
studied samples presented completely diﬀerent profiles;
C. oﬃcinalis presented thirteen diﬀerent compounds,
mainly glycosylated flavonols, while M. cervina presented
eleven compounds, mainly caﬀeoyl derivatives (caﬀeic acid
dimers, trimers and tetramers). In the literature there are
several studies regarding the phenolic composition of
C. oﬃcinalis,22,31–36 while for M. cervina only one study was
found.26 Nevertheless, the phenolic profile of the infusions,
the most common form of consumption of this plant, are
limited.
The C. oﬃcinalis (marigold) phenolic profile presented two
phenolic acids (compounds 1 and 2) and eleven flavonol
derivatives (compounds 3–13). 5-O-Caﬀeoylquinic acid (chloro-
genic acid, compound 2), quercetin-3-O-rutinoside (rutin; com-
pound 4), isorhamnetin-3-O-rutinoside (narcissin; compound
11) and isorhamnetin-3-O-glucoside (compound 12) were posi-
tively identified according to their retention times, mass and
UV-vis characteristics by comparison with commercial
standards. These compounds have been previously reported by
other authors in diﬀerent tissues32,33,35,36 and pollen of
Table 2 Chemical composition in free sugars, organic acids and tocopherols of plant dry material and infusions of C. oﬃcinalis and M. cervina
Dry material Infusions
C. oﬃcinalis M. cervina C. oﬃcinalis M. cervina
Sugars (g per 100 g) (g per 100 g) Student’s t-test p-value (mg per 100 mL) (mg per 100 mL) Student’s t-test p-value
Xylose 1.70 ± 0.02 nd — nd nd —
Fructose 4.7 ± 0.3 3.3 ± 0.1 <0.001 19 ± 1 12 ± 1 <0.001
Glucose 0.8 ± 0.1 3.5 ± 0.1 <0.001 7 ± 1 16 ± 1 <0.001
Sucrose 3.9 ± 0.1 2.13 ± 0.04 <0.001 14 ± 1 10 ± 1 0.022
Trehalose 0.6 ± 0.1 0.65 ± 0.01 0.248 9 ± 1 nd —
Sum 11.7 ± 0.2 9.66 ± 0.01 <0.001 49 ± 1 38 ± 5 0.012
Organic acids (mg per 100 g) (mg per 100 g) (mg per 100 mL) (mg per 100 mL)
Oxalic acid 718 ± 7 275 ± 2 <0.001 0.35 ± 0.01 tr —
Quinic acid 392 ± 3 54 ± 2 <0.001 tr tr —
Malic acid 743 ± 15 144 ± 2 <0.001 tr tr —
Citric acid 963 ± 23 226 ± 7 <0.001 2.64 ± 0.05 0.82 ± 0.02 <0.001
Fumaric acid 13.6 ± 0.3 0.46 ± 0.01 <0.001 0.040 ± 0.001 tr —
Sum 2830 ± 12 700 ± 5 <0.001 3.02 ± 0.04 0.82 ± 0.02 <0.001
Tocopherols (mg per 100 g) (mg per 100 g) (µg per 100 mL) (µg per 100 mL)
α-Tocopherol 19.40 ± 0.01 1.94 ± 0.04 <0.001 0.881 ± 0.001 0.143 ± 0.003 <0.001
β-Tocopherol 1.48 ± 0.08 nd — nd nd —
γ-Tocopherol 2.45 ± 0.06 nd — nd nd —
δ-Tocopherol nd 0.050 ± 0.001 — nd nd —
Sum 23.33 ± 0.01 1.99 ± 0.04 <0.001 0.881 ± 0.001 0.143 ± 0.003 <0.001
nd – not detected; tr – traces. In each row, p < 0.05 means significant diﬀerences.
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C. oﬃcinalis,34 as well as in marigold tinctures31 and infusions
and decoctions.22
Compound 1 ([M − H]− at m/z 341) was identified as a
caﬀeic acid hexoside. The remaining phenolic compounds cor-
responded to flavonol derivatives, derived from quercetin (λmax
around 350 nm and MS2 fragment at m/z 301), kaempferol
(λmax around 348 nm, MS
2 fragment at m/z 285) and isorham-
netin (λmax at 354 nm, MS
2 fragment at m/z 315). Compounds
3 ([M − H]− at m/z 755), 5 ([M − H]− at m/z 739) and
6 ([M − H]− at m/z 769), should respectively correspond to
quercetin, kaempferol and isorhamnetin derivatives bearing
two deoxyhexosyl and one hexosyl residues. The fact that only
one MS2 fragment was released corresponding to the aglycone
would suggest that the three sugars constitute a trisaccharide.
Compounds similar to 3 and 6 have been previously described
in marigold tissues32,33,35 and herbal preparations,22,31 and
identified respectively as quercetin 3-O-2G-rhamnosylrutino-
side (manghaslin) and isorhamnetin 3-O-2G-rhamnosylrutino-
side (typhaneoside).37 Compound 5 corresponds to the
equivalent kaempferol derivative that, as far as we know, has
not been reported previously in marigold.
Compound 7 presented a pseudomolecular ion [M − H]− at
m/z 595, releasing an MS2 fragment at m/z 301 ([M − H-132-
162]−, loss of pentosyl and hexosyl moieties), which allowed its
tentative identification as quercetin-O-pentosylhexoside. Com-
pound 8 ([M − H]− at m/z 651) was 42 u (acetyl residue) higher
than compound 4 (rutin); nevertheless, since the actual nature
of the glycosyl residue could not be confirmed, it was just
assigned as quercetin-O-acetyldeoxyhexosylhexoside. Peak 9
([M − H]− at m/z 623) showed identical UV and mass character-
istics to compound 11 (isorhamnetin 3-O-rutinoside) but
eluted a bit earlier. A similar compound was reported by Olen-
nikov and Kashchenko35,36 and Ukiya et al.7 in marigold
flowers and identified as isorhamnetin-3-O-neohesperidoside
(calendoflavoside), so that this identity was assumed for the
compound detected herein. Compounds 10 and 13 presented
pseudomolecular ions [M − H]− at m/z 505 and 519 releasing
MS2 fragments at m/z 301 (quercetin) and at m/z 315 (isorham-
netin), respectively, indicating the loss of an acetylhexoside
residue ([M − H-42-162]−). Similar compounds were also
identified in marigold by Olennikov and Kashchenko35,36 as
quercetin-3-O-(6″-acetyl)-glucoside and isorhamnetin-3-O-(6″-
acetyl)-glucoside, respectively; the latter one was also found in
infusions and decoctions of marigold.22 These identities were
also assumed for the compounds detected in our samples.
Isorhamnetin-3-O-rhamnosylrutinoside (typhaneoside; peak
6) and isorhamnetin-3-O-rutinoside (narcissin, peak 11) were
the most abundant phenolics in the analyzed extracts and
infusions of marigold (Table 5). These compounds were also
reported as the main phenolic compounds in C. oﬃcinalis
flowers.35
As mentioned above, the phenolic composition of
M. cervina was characterised by the presence of caﬀeoyl deriva-
tives, namely caﬀeic acid dimers, trimers and tetramers, com-
pounds which have not been reported before in this species.
To the best of our knowledge, the only study that reports on
the phenolic composition of M. cervina was published by Politi
et al.,26 who identified four phenolic acids (protocatechuic
acid, p-coumaric acid, caﬀeic acid and chlorogenic acid) and
three flavonoids (epicatechin, orientin and rutin). The only
common compound between the ones reported in that study
and those detected herein was caﬀeic acid (compound 2′). This
latter and trans-rosmarinic acid (compound 9′) were positively
identified according to their retention times, mass and UV-vis
characteristics by comparison with commercial standards.
Compound 5′ ([M − H]− at m/z 521) yielded a fragment at m/z
359 (rosmarinic acid) from the loss of 162 mu (hexoside
moiety), as well as other fragments identical to those observed
for compound 9′, which allowed its tentative identification
as rosmarinic acid hexoside. Furthermore, compound 8′
with similar characteristics to compound 9′ should correspond
to a rosmarinic acid isomer that was tentatively identified as
cis-rosmarinic acid.
Compound 1′ ([M − H]− at m/z 433) was assigned as a
caﬀeic acid derivative based on the characteristic fragment
Table 3 Fatty acid composition in the dry material of C. oﬃcinalis and
M. cervina
Calendula
oﬃcinalis
Mentha
cervina
Student’s t-test
p-value
C4:0 1.43 ± 0.08 — —
C6:0 0.51 ± 0.03 0.37 ± 0.01 <0.001
C8:0 0.66 ± 0.02 0.27 ± 0.01 <0.001
C10:0 0.28 ± 0.01 0.11 ± 0.01 <0.001
C12:0 3.66 ± 0.09 0.31 ± 0.01 <0.001
C13:0 0.050 ± 0.001 1.85 ± 0.02 <0.001
C14:0 24.93 ± 0.27 1.22 ± 0.16 <0.001
C14:1 0.10 ± 0.01 — —
C15:0 0.46 ± 0.01 — —
C16:0 35.57 ± 0.11 20.95 ± 0.48 <0.001
C16:1 0.21 ± 0.03 1.06 ± 0.02 <0.001
C17:0 0.47 ± 0.02 0.66 ± 0.07 0.003
C18:0 5.93 ± 0.18 4.01 ± 0.34 <0.001
C18:1n9 2.47 ± 0.01 8.04 ± 0.80 <0.001
C18:2n6 9.32 ± 0.02 10.45 ± 0.23 <0.001
C18:3n3 11.08 ± 0.10 45.65 ± 0.50 <0.001
C20:0 0.80 ± 0.01 1.95 ± 0.07 <0.001
C20:1 0.12 ± 0.01 — —
C20:3n3+C21:0 0.77 ± 0.02 0.31 ± 0.06 <0.001
C22:0 0.33 ± 0.02 1.30 ± 0.02 <0.001
C22:1n9 — 0.40 ± 0.02 —
C23:0 — 0.19 ± 0.02 —
C24:0 0.88 ± 0.02 0.89 ± 0.02 0.261
SFA (percentage) 76.70 ± 0.16 34.08 ± 0.98 <0.001
MUFA (percentage) 2.78 ± 0.05 9.51 ± 0.56 <0.001
PUFA (percentage) 20.51 ± 0.13 56.42 ± 0.21 <0.001
The results of fatty acids are expressed in relative percentage. In each
row, p < 0.05 means significant diﬀerences. Butyric acid (C4:0); caproic
acid (C6:0); caprylic acid (C8:0); capric acid (C10:0); lauric acid (C12:0);
tridecanoic acid (C13:0); myristic acid (C14:0); myristoleic acid (C14:1);
pentadecanoic acid (C15:0); palmitic acid (C16:0); palmitoleic acid
(C16:1); heptadecanoic acid (C17:0); stearic acid (C18:0); oleic acid
(C18:1n9c); linoleic acid (C18:2n6c); α-linolenic acid (C18:3n3);
arachidic acid (C20:0); eicosenoic acid (C20:1); cis-11,14,17-
eicosatrienoic acid and heneicosanoic acid (C20:3n3 + C21:0); behenic
acid (C22:0); lignoceric acid (C24:0). SFA – saturated fatty acids; MUFA
–monounsaturated fatty acids; PUFA – polyunsaturated fatty acids.
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ions at m/z 179 [caﬀeic acid-H]− and 135 [caﬀeic acid-CO2–H]
−.
Nevertheless, no definite structure could be matched to the
molecular mass of the compound that remains as an un-
identified caﬀeic acid derivative. Compound 3′ presented a
pseudomolecular ion [M − H]− at m/z 537, the UV spectrum
and fragmentation pattern being consistent with the caﬀeic
acid trimer lithospermic acid A. This compound can easily
lose the 8″-carboxyl group (−44 u) releasing a fragment at m/z
493 that further breaks down to form the fragment ions at m/z
313 and 295. However, peak 3′ showed a diﬀerent retention
time compared to lithospermic acid A, which is expected to
elute later than trans-rosmarinic acid, as previously observed
in other Lamiaceae analyzed in our laboratory.29,38 Other com-
pounds with the same molecular weight are salvianolic acids
H or I, although they showed diﬀerent fragmentation pat-
terns.39,40 A compound with similar characteristics was found
in a sample of Melissa oﬃcinalis and identified as a lithosper-
mic acid A isomer,29 an identity that has been tentatively
assumed for peak 3′ detected herein.
Compounds 4′ and 6′ ([M − H]− at m/z 539) presented the
same pseudomolecular ion and similar fragmentation pattern
and UV spectra, coherent with those of yunnaneic acid D as
described by Chen et al.39 in Salvia miltiorrhiza, based on
which they were identified as yunnaneic acid D isomers. Com-
pound 7′ showed a pseudomolecular ion [M − H]− at m/z 719
and an MS2 majority fragment at m/z 359 corresponding to
[M − 2H]2−; these mass characteristics coincided with those of
sagerinic acid, a rosmarinic acid dimer, reported by us in
other plant samples.29,38 Finally, compounds 10′ and 11′ also
presented the same pseudomolecular ion [M − H]− at m/z 493,
which together with the characteristic fragment ions at m/z
313, 295 and 197 and UV spectra allowed assigning them as
salvianolic acid A isomers, e.g., isosalvianolic acid A and salvia-
nolic acid A, as previously described by Ruan et al.40
Rosmarinic acid was the most abundant phenolic com-
pound in M. cervina. This compound had not been identified
in the only report previously published on the phenolic com-
position of this species,26 which described a completely
diﬀerent phenolic profile.
3.3. Bioactivity of C. oﬃcinalis and M. cervina
hydromethanolic extracts and infusions
The in vitro antioxidant and cytotoxic properties of
C. oﬃcinalis and M. cervina, hydromethanolic extracts and
infusions were evaluated, and the results are given in Table 6.
Table 4 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data and identiﬁcation of phenolic com-
pounds in C. oﬃcinalis and M. cervina hydromethanolic extracts and infusions
Compound
Rt
(min)
λmax
(nm)
Molecular ion
[M − H]− (m/z) MS2 (m/z) Tentative identification
C. oﬃcinalis
1 7.0 320 341 179(100), 161(3), 135(40) Caﬀeic acid hexoside
2 7.6 328 353 191(100), 179(8), 173(6), 161(11), 135(3) 5-O-Caﬀeoylquinic acid
3 15.1 350 755 301(100) Quercetin-3-O-rhamnosylrutinoside
4 16.7 354 609 301(100) Quercetin-3-O-rutinoside
5 17.1 348 739 285(100) Kaempferol-O-rhamnosylrutinoside
6 17.5 356 769 315(100), 300(10) Isorhamnetin-3-O-
rhamnosylrutinoside
7 18.3 350 595 301(100) Quercetin-O-pentosylhexoside
8 18.5 350 651 609(5), 301(50) Quercetin-O-
acetyldeoxyhexosylhexoside
9 19.6 356 623 315(100), 300(18) Isorhamnetin-3-O-neohesperidoside
10 21.2 356 505 301(65) Quercetin-3-O-(6″-acetyl)-glucoside
11 22.7 356 623 315(100), 300(10) Isorhamnetin-3-O-rutinoside
12 24.2 354 477 315(100), 300(15) Isorhamnetin-3-O-glucoside
13 26.9 354 519 315(100), 300(37) Isorhamnetin-3-O-(6″-acetyl)-
glucoside
M. cervina
1′ 4.7 282 433 235(100), 197(25), 179(17), 135(6) Caﬀeic acid derivative
2′ 10.7 324 179 135(100) Caﬀeic acid
3′ 15.4 326 537 493(59), 339(100), 313(21), 295(37),
269(14), 229(8), 197(33), 179(22), 135(24)
Lithospermic acid A isomer
4′ 16.6 272, 324sh 539 495(13), 359(21), 297(100), 279(64), 197(34),
179(36), 161(34), 135(18)
Yunnaneic acid D isomer
5′ 18.2 322 521 359(100), 197(21), 179(34), 161(73), 135(15) Rosmarinic acid hexoside
6′ 18.5 274, 324sh 539 495(44), 359(28), 297(100), 279(11), 197(33),
179(31), 161(84), 135(16)
Yunnaneic acid D isomer
7′ 20.0 276 719 539(12), 521(10), 359(65), 197(6), 179(8), 161(17), 135(3) Sagerinic acid
8′ 22.4 328 359 197(22), 179(27), 161(100), 135(14) cis-Rosmarinic acid isomer
9′ 23.3 328 359 197(30), 179(54), 161(100), 135(7) trans-Rosmarinic acid
10′ 26.7 326 493 359(85), 313(9), 295(71), 269(8), 197(33), 179(44),
161(100), 135(90)
Isosalvianolic acid A
11′ 31.6 324 493 359(84), 313(13), 295(58), 269(7), 197(31), 179(41),
161(91), 135(86)
Salvianolic acid A
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Table 5 Quantiﬁcation of phenolic compounds in C. oﬃcinalis and M. cervina infusions (µg per 100 mL) and hydromethanolic extracts (mg per
100 g extract)
Calendula oﬃcinalis Mentha cervina
Compounds Infusion
Hydromethanolic
extract Compounds Infusion
Hydromethanolic
extract
Caﬀeic acid hexoside 41 ± 1 6.41 ± 0.02 Caﬀeic acid derivative 104 ± 2 16.1 ± 0.2
5-O-Caﬀeoylquinic acid 149 ± 3 33.32 ± 0.01 Caﬀeic acid 96 ± 1 23 ± 2
Quercetin-3-O-rhamnosylrutinoside 134 ± 3 28.58 ± 0.04 Lithospermic acid A isomer 162 ± 16 10 ± 1
Quercetin-3-O-rutinoside 95 ± 3 22 ± 1 Yunnaneic acid D isomer 262 ± 8 31 ± 3
Kaempferol-O-rhamnosylrutinoside 59 ± 6 10.0 ± 0.4 Rosmarinic acid hexoside 195 ± 1 30 ± 5
Isorhamnetin-3-O-rhamnosylrutinoside 1547 ± 9 305 ± 8 Yunnaneic acid D isomer 295 ± 15 30.2 ± 0.4
Quercetin-O-pentosylhexoside 34 ± 1 8.0 ± 0.1 Sagerinic acid 333 ± 7 42 ± 1
Quercetin-O-acetyldeoxyhexosylhexoside 23 ± 2 3.8 ± 0.1 cis-Rosmarinic acid 441 ± 25 68 ± 4
Isorhamnetin-3-O-neohesperidoside 316 ± 8 66.5 ± 0.4 trans-Rosmarinic acid 3224 ± 88 754 ± 2
Quercetin-3-O-(6″-acetyl)-glucoside 102 ± 5 20 ± 1 Isosalvianolic acid A 31 ± 2 27 ± 1
Isorhamnetin-3-O-rutinoside 1408 ± 11 288 ± 1 Salvianolic acid A 234 ± 23 23 ± 1
Isorhamnetin-3-O-glucoside 111 ± 3 18 ± 1
Isorhamnetin-3-O-(6″-acetyl)-glucoside 334 ± 4 51 ± 2
Total phenolic acids 190 ± 2 39.73 ± 0.02 5376 ± 88 1053 ± 13
Total flavonoids 4161 ± 19 821 ± 9 nd nd
Total phenolic compounds 4351 ± 19 861 ± 9 5376 ± 88 1053 ± 13
nd – not detected.
Fig. 1 Phenolic proﬁle of C. oﬃcinalis (A) and M. cervina (B) recorded at 370 and 280 nm, respectively.
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The highest antioxidant activity was observed for
M. cervina; its hydromethanolic extract showed the lowest EC50
values in all the assays, except in the β-carotene bleaching inhi-
bition, where C. oﬃcinalis infusion gave higher antioxidant
activity. These diﬀerences could be related with the diﬀerent
phenolic profiles of each plant (Table 5). Whereas M. cervina
showed phenolic acid derivatives as the major compounds,
C. oﬃcinalis proved to have flavonoids as the main phenolic
molecules. The in vitro as also the in vivo antioxidant activity
of C. oﬃcinalis has been previously reported.4,18–20 The results
of the extracts studied revealed a DPPH radical scavenging
activity lower than that of aqueous extracts and hydromethano-
lic extracts obtained by Ćetković et al.19 (EC50: 0.30–0.90 mg
mL−1). All the publications confirmed the antioxidant capacity
of C. oﬃcinalis, suggesting that many of its therapeutic activi-
ties are due to that capacity.
Regarding antitumor potential, the most promising results
were obtained for the M. cervina hydromethanolic extract,
which exhibited cytotoxicity against the four tested tumor cell
lines, being more active against cervical carcinoma (HeLa, GI50 =
223 µg mL−1). The hydromethanolic extract of C. oﬃcinalis
revealed selectivity against cervical (HeLa, GI50 = 256 µg mL
−1)
and hepatocellular (HepG2, GI50 = 330 µg mL
−1) carcinoma.
The infusions of both plants did not show eﬀects on the
tumor cell lines, however, and none of the extracts revealed
toxicity against non-tumor cells (PLP2). In contrast to the lack
of studies with M. cervina in this regard, there are some
reports that evaluate the antitumor activity of C. oﬃcinalis
extracts and isolated compounds by using in vitro and in vivo
models.7,21,22 The antitumor activity of triterpene glycosides
isolated from marigold was shown by Ukiya et al.,7 and the
results obtained by Matić et al.22 on marigold infusion against
HeLa (GI50 = 750 µg mL
−1) and other tumor cell lines, are con-
sistent with the present study.
In summary, C. oﬃcinalis (marigold flowers) and M. cervina
(Hart’s pennyroyal leaves) contain phytochemicals that are of
great interest due to their potential antioxidant and antitumor
activities. Overall, the present study extends the knowledge of
C. oﬃcinalis and provides innovative results for M. cervina
regarding chemical characterization and bioactive properties,
contributing to extend their use as functional ingredients, and
for medical purposes.
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